221 related articles for article (PubMed ID: 17171193)
1. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
Timely Top Med Cardiovasc Dis; 2007 Feb; 11():E7. PubMed ID: 17380217
[TBL] [Abstract][Full Text] [Related]
3. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
[TBL] [Abstract][Full Text] [Related]
4. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
[TBL] [Abstract][Full Text] [Related]
5. [Cognitive dysfunction and dementia associated with elderly diabetes].
Kouta Y; Sakurai T; Yokono K
Nihon Rinsho; 2006 Jan; 64(1):119-23. PubMed ID: 16408458
[TBL] [Abstract][Full Text] [Related]
6. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus.
Bruehl H; Wolf OT; Sweat V; Tirsi A; Richardson S; Convit A
Brain Res; 2009 Jul; 1280():186-94. PubMed ID: 19463794
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome.
Borshchev YY; Uspensky YP; Galagudza MM
Life Sci; 2019 Nov; 237():116932. PubMed ID: 31606384
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition.
van den Berg E; Kloppenborg RP; Kessels RP; Kappelle LJ; Biessels GJ
Biochim Biophys Acta; 2009 May; 1792(5):470-81. PubMed ID: 18848880
[TBL] [Abstract][Full Text] [Related]
9. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?
Biessels GJ; Reijmer YD
Diabetes; 2014 Jul; 63(7):2244-52. PubMed ID: 24931032
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunction in patients with type 2 diabetes.
Reijmer YD; van den Berg E; Ruis C; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2010 Oct; 26(7):507-19. PubMed ID: 20799243
[TBL] [Abstract][Full Text] [Related]
11. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
Verdelho A; Madureira S; Moleiro C; Ferro JM; Santos CO; Erkinjuntti T; Pantoni L; Fazekas F; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D;
Neurology; 2010 Jul; 75(2):160-7. PubMed ID: 20625169
[TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction and diabetes: implications for primary care.
Biessels GJ; Kerssen A; de Haan EH; Kappelle LJ
Prim Care Diabetes; 2007 Dec; 1(4):187-93. PubMed ID: 18632044
[TBL] [Abstract][Full Text] [Related]
13. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes.
de Bresser J; Reijmer YD; van den Berg E; Breedijk MA; Kappelle LJ; Viergever MA; Biessels GJ;
Dement Geriatr Cogn Disord; 2010; 30(5):381-6. PubMed ID: 20962529
[TBL] [Abstract][Full Text] [Related]
14. Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study.
Bruce DG; Davis WA; Starkstein SE; Davis TM
J Alzheimers Dis; 2014; 42 Suppl 3():S63-70. PubMed ID: 24840567
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine.
Everson-Rose SA; Ryan JP
Psychosom Med; 2015; 77(6):612-5. PubMed ID: 26163814
[TBL] [Abstract][Full Text] [Related]
16. Vascular basis for brain degeneration: faltering controls and risk factors for dementia.
Kalaria RN
Nutr Rev; 2010 Dec; 68 Suppl 2(Suppl 2):S74-87. PubMed ID: 21091952
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.
Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K
Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432
[TBL] [Abstract][Full Text] [Related]
18. Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study.
Raffield LM; Cox AJ; Hugenschmidt CE; Freedman BI; Langefeld CD; Williamson JD; Hsu FC; Maldjian JA; Bowden DW
Neurobiol Aging; 2015 Mar; 36(3):1602.e7-15. PubMed ID: 25523635
[TBL] [Abstract][Full Text] [Related]
19. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
Calvo-Ochoa E; Arias C
Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
[TBL] [Abstract][Full Text] [Related]
20. Aggravated cognitive and brain functional impairment in mild cognitive impairment patients with type 2 diabetes: a resting-state functional MRI study.
Zhou X; Zhang J; Chen Y; Ma T; Wang Y; Wang J; Zhang Z
J Alzheimers Dis; 2014; 41(3):925-35. PubMed ID: 24705547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
